API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207653
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212171
https://www.biospectrumindia.com/news/43/14197/sun-pharma-launches-rosuvastatin-for-lipid-disorder-treatment.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207626
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206513
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208850
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207375
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208898
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205587
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206465
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207453
http://www.bloomberg.com/news/articles/2016-07-20/indian-firms-get-approval-for-generics-of-astrazeneca-s-crestor
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-gets-fda-nod-for-rosuvastatin-calcium-tablets/articleshow/53297791.cms
https://www.pharmacompass.com/pdf/news/apotex-receives-fda-nod-for-rosuvastatin-calcium-to-treat-hypercholesterolemia-1469262216.pdf
https://www.pharmacompass.com/pdf/news/mylan-receives-fda-nod-for-rosuvastatin-calcium-to-treat-hypercholesterolemia-1469262191.pdf
https://www.pharmacompass.com/pdf/news/teva-receives-fda-nod-for-rosuvastatin-calcium-to-treat-hypercholesterolemia-1469262163.pdf
https://www.pharmacompass.com/pdf/news/par-pharm-receives-fda-nod-for-rosuvastatin-to-treat-hypercholesterolemia-1469262136.pdf
https://www.pharmacompass.com/pdf/news/sun-pharma-receives-fda-nod-for-rosuvastatin-to-treat-hypercholesterolemia-1469262110.pdf
https://www.pharmacompass.com/pdf/news/aurobindo-receives-fda-nod-for-rosuvastatin-to-treat-hypercholesterolemia-1469262083.pdf
https://www.pharmacompass.com/pdf/news/sandoz-receives-fda-nod-for-rosuvastatin-calcium-to-treat-hypercholesterolemia-1469262043.pdf
https://www.pharmacompass.com/pdf/news/glenmark-receives-fda-nod-for-rosuvastatin-calcium-to-treat-hypercholesterolemia-1469262011.pdf
http://twofourinsight.com/generic-crestor-market-become-crowded-near-future/
https://www.pharmacompass.com/pdf/news/watsons-generic-rosuvastatin-calcium-approved-in-us-for-the-treatment-of-dyslipidemia-1462269294.pdf
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/europe-approves-biocons-rosuvastatin-calcium-tablets/articleshow/51002743.cms
http://www.bloomberg.com/news/articles/2015-03-20/astrazeneca-lags-in-cancer-race-where-losing-may-invite-takeover?cmpid=yhoo
http://www.fiercepharma.com/story/moodys-big-pharmas-face-growing-patent-loss-threats-some-pipelines-are-impr/2015-02-03